Goodbody Health Limited (OTCQB: GDBYF / AQSE: GDBY) – Gaining Traction for New Services
Highlights Q3 revenue was down 62% YoY, and 16% QoQ, beating our estimate by 14%. EPS was 6%...
Read MoreHighlights Q3 revenue was down 62% YoY, and 16% QoQ, beating our estimate by 14%. EPS was 6%...
Read MoreHighlights Q3 production was up 23% YoY, and in line with our estimate. However, revenue was up...
Read MoreHighlights This company is a financial technology (fintech) company that just launched a platform...
Read MoreHighlights Q2 results were in line with our expectations. EPS increased YoY from $0.01 to $0.19...
Read MoreHighlights In Q2-2022, this company generated £2.2M in revenue, down 36% YoY, missing our estimate...
Read MoreHighlights This company is a Special Purpose Acquisition Company (“SPAC”), with $86M in cash, and...
Read MoreHighlights Flagship subsidiary Belle Pulses (a processor of crops/pulses) generated $15.2M in...
Read MoreHighlights Founded in 2019, this company is a Las Vegas based company with subsidiaries operating...
Read MoreHighlights Being an investment company, this company does not report revenue/profit of its...
Read MoreHighlights This company offers CBD products ranging from oils, capsules, topicals, to pet...
Read More